These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11006476)

  • 1. Antimalarial drug development and new targets.
    Macreadie I; Ginsburg H; Sirawaraporn W; Tilley L
    Parasitol Today; 2000 Oct; 16(10):438-44. PubMed ID: 11006476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mode of action and the mechanism of resistance to antimalarial drugs.
    Foote SJ; Cowman AF
    Acta Trop; 1994 Mar; 56(2-3):157-71. PubMed ID: 8203302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in antimalarial compounds and their patents.
    Mital A
    Curr Med Chem; 2007; 14(7):759-73. PubMed ID: 17346161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative folate metabolism in humans and malaria parasites (part I): pointers for malaria treatment from cancer chemotherapy.
    Nzila A; Ward SA; Marsh K; Sims PF; Hyde JE
    Trends Parasitol; 2005 Jun; 21(6):292-8. PubMed ID: 15922251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular approaches to the spreading problem of drug resistant malaria.
    Plowe CV; Wellems TE
    Adv Exp Med Biol; 1995; 390():197-209. PubMed ID: 8718614
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemoresistance in falciparum malaria.
    May J; Meyer CG
    Trends Parasitol; 2003 Oct; 19(10):432-5; discussion 435-6. PubMed ID: 14519577
    [No Abstract]   [Full Text] [Related]  

  • 7. The past, present and future of antifolates in the treatment of Plasmodium falciparum infection.
    Nzila A
    J Antimicrob Chemother; 2006 Jun; 57(6):1043-54. PubMed ID: 16617066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicases - feasible antimalarial drug target for Plasmodium falciparum.
    Tuteja R
    FEBS J; 2007 Sep; 274(18):4699-704. PubMed ID: 17824956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs.
    Hyde JE
    Microbes Infect; 2002 Feb; 4(2):165-74. PubMed ID: 11880048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial drugs: modes of action and mechanisms of parasite resistance.
    Müller IB; Hyde JE
    Future Microbiol; 2010 Dec; 5(12):1857-73. PubMed ID: 21155666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance hampers our capacity to roll back malaria.
    Olliaro P
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S247-57. PubMed ID: 16032560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimalarial chemotherapy: young guns or back to the future?
    Biagini GA; O'Neill PM; Nzila A; Ward SA; Bray PG
    Trends Parasitol; 2003 Nov; 19(11):479-87. PubMed ID: 14580958
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.
    Gardiner DL; Skinner-Adams TS; Brown CL; Andrews KT; Stack CM; McCarthy JS; Dalton JP; Trenholme KR
    Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1087-98. PubMed ID: 19883329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and physiologic basis of quinoline drug resistance in Plasmodium falciparum malaria.
    Roepe PD
    Future Microbiol; 2009 May; 4(4):441-55. PubMed ID: 19416013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
    Basco LK; Ringwald P
    Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activity of PS-15 in combination with sulfamethoxazole.
    Yeo AE; Rieckmann KH
    Trop Med Parasitol; 1994 Jun; 45(2):136-7. PubMed ID: 7939165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular assays for surveillance of antifolate-resistant malaria.
    Kublin JG; Witzig RS; Shankar AH; Zurita JQ; Gilman RH; Guarda JA; Cortese JF; Plowe CV
    Lancet; 1998 May; 351(9116):1629-30. PubMed ID: 9620719
    [No Abstract]   [Full Text] [Related]  

  • 18. Malaria resistance to non-artemisinin partner drugs: how to reACT.
    van Schalkwyk DA; Sutherland CJ
    Lancet Infect Dis; 2015 Jun; 15(6):621-3. PubMed ID: 25877961
    [No Abstract]   [Full Text] [Related]  

  • 19. Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand.
    Wilairatana P; Kyle DE; Looareesuwan S; Chinwongprom K; Amradee S; White NJ; Watkins WM
    Ann Trop Med Parasitol; 1997 Mar; 91(2):125-32. PubMed ID: 9307653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of resistance of malaria parasites to antifolates.
    Gregson A; Plowe CV
    Pharmacol Rev; 2005 Mar; 57(1):117-45. PubMed ID: 15734729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.